Standard or custom package
excellent quality and reliable supplier
*The following content is generated by AI and is for reference only.
Overview
Idealisib (CAS: 1062549-78-9) is a potent PI3Kδ inhibitor synthesized via multi-step organic catalysis. Its molecular formula is C21H23F2N5O, primarily produced for pharmaceutical API manufacturing.
Application
- Oncology research targeting B-cell malignancies like CLL and SLL.
- Development of targeted therapies for lymphoid cancers.
- Quality control standards in clinical trial drug formulation.
Precautions
Strictly regulated as an investigational new drug (IND). Storage requires controlled temperature (-20°C) under inert atmosphere to prevent degradation. Handling mandates PPE due to potential hepatotoxicity risks.